Catalyst Wire Dossier Catalyst Wire Dossier

Odalasvir

odalasvir · Janssen Research & Development, LLC
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Odalasvir, covering 2017-01-23 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Pharmacokinetic Interaction Study Between Odalasvir, Given as a Single Agent or in Combination With Simeprevir, and Dabigatran Etexilate Mesylate in Healthy Participants [Phase 1]

See pricing